查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586067

大麻藥品市場：按品牌、產品類型、適應症、分銷管道 - 全球預測 2025-2030

Cannabis Pharmaceuticals Market by Brand (Epidiolex, Sativex), Product Type (Ointments & Creams, Solids and Dissolvable Powder & Oil), Indication, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年大麻藥品市場價值為14.4億美元，預計2024年將達到17.1億美元，複合年成長率為18.75%，到2030年將達到48.2億美元。

大麻醫藥市場包括源自大麻化合物的醫藥級產品的研究、開發和商業化，主要是大麻二酚（CBD）和四氫大麻酚（THC）等大麻素。人們擴大接受大麻衍生藥物來治療癲癇、慢性疼痛、多發性硬化症和癌症相關疾病，從而推動了該領域的發展。大麻藥物的需求源於其比傳統藥物具有治療功效且副作用更少的承諾。應用包括疼痛管理、神經病學、腫瘤學和安寧療，最終用戶包括醫院、診所、製藥公司和研究機構。關鍵的成長要素包括合法化程度的提高、消費者意識的提高以及證明大麻治療有效性的持續研究。此外，在擴大監管核准、開發新型輸送系統以及利用與生物技術產業的協同效應效應方面也存在潛在機會。然而，市場面臨監管障礙、地區接受度不同、研究成本高等限制。智慧財產權挑戰和供應鏈問題使這些障礙更加複雜。此外，社會偏見和嚴格臨床試驗的要求是阻礙市場擴張的主要挑戰。為了充分利用成長機會，公司應專注於創新，例如先進的萃取技術、精密配方方法和針對特定基因譜和條件的個人化醫療方法。將人工智慧和資料分析整合到研究中可以深入了解患者反應的變化並最佳化產品開發平臺。總體而言，市場呈現出動態的特點，以快速的技術進步和不斷變化的法律制度為特徵，為相關人員創造了機會和挑戰。透過與研究機構建立強力的合作並倡導更清晰的監管環境，您可以增加成長前景並更順利地駕馭不斷變化的環境。

主要市場統計
基準年[2023] 14.4億美元
預測年份 [2024] 17.1億美元
預測年份 [2030] 48.2億美元
複合年成長率（%） 18.75%

市場動態：揭示快速發展的大麻藥品市場的關鍵市場洞察

供需的動態交互作用正在改變大麻藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球藥用大麻合法化程度不斷提高
    • 人們越來越認知到大麻二酚的醫療益處及其治療特性
    • 擴大使用大麻為基礎的藥物來治療發炎、慢性疼痛和睡眠障礙等各種適應症
  • 市場限制因素
    • 與醫用大麻相關的高價格
  • 市場機會
    • 增加對大麻藥物的投資
    • 擴大線上和零售藥局的供應範圍
  • 市場挑戰
    • 多個國家對大麻萃取物合法化有嚴格規定

波特的五力：駕馭大麻醫藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解大麻藥品市場的外部影響

外部宏觀環境因素在塑造大麻藥品市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解大麻藥品市場的競爭格局

對大麻製藥市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 大麻藥品市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估大麻製藥市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議為大麻藥品市場的成功指明了道路

大麻製藥市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地醫用大麻合法化程度不斷提高
      • 人們越來越認知到大麻二酚的醫療益處及其治療特性
      • 以大麻為基礎的藥物擴大用於治療發炎、慢性疼痛和睡眠障礙等各種適應症。
    • 抑制因素
      • 醫用大麻價格高
    • 機會
      • 增加對大麻藥物的投資
      • 透過線上和零售藥局增加可用性
    • 任務
      • 一些國家對大麻萃取物。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章以品牌分類的大麻藥品市場

  • Epidiolex
  • 薩蒂克斯

第7章 大麻藥品市場：依產品類型

  • 軟膏和霜
  • 固態、可溶性粉末和油

第8章以適應症分類的大麻藥品市場

  • 關節炎
  • 癌症
  • 癲癇
  • 偏頭痛

第9章 大麻藥品市場：按分銷管道

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章美洲大麻藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太大麻藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的大麻藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Bausch Health Companies, Inc.
  • Botanix Pharmaceuticals
  • Breath of Life Pharma, Ltd.
  • Cannabis Science, Inc.
  • Cannamedical Pharma GmbH
  • Canopy Growth Corporation
  • Cara Therapeutics Inc.
  • CB Therapeutics Inc.
  • Celadon Pharmaceuticals PLC
  • Corbus Pharmaceuticals Holdings, Inc.
  • Cronos Group Inc. By Altria Group
  • Green Thumb Industries
  • Jazz Pharmaceuticals PLC
  • Medical Marijuana Inc.
  • MGC Pharmaceuticals Limited
  • Panaxia Pharmaceutical Industries
  • Pascal Biosciences Inc.
  • PharmaCyte Biotech, Inc.
  • Renew Biopharma, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tilray Brands, Inc.
  • Zynerba Pharmaceuticals, Inc. by Harmony Biosciences
Product Code: MRR-221461476B43

The Cannabis Pharmaceuticals Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.71 billion in 2024, and is projected to grow at a CAGR of 18.75%, to USD 4.82 billion by 2030.

The cannabis pharmaceuticals market encompasses the research, development, and commercialization of pharmaceutical-grade products derived from cannabis compounds, primarily cannabinoids like cannabidiol (CBD) and tetrahydrocannabinol (THC). This sector is driven by the growing acceptance of cannabis-derived medications for treating conditions such as epilepsy, chronic pain, multiple sclerosis, and cancer-related symptoms. The necessity for cannabis pharmaceuticals arises from their potential to offer therapeutic benefits with fewer side effects compared to traditional pharmaceuticals. The application scope spans across pain management, neurology, oncology, and palliative care, with end-users including hospitals, clinics, pharmaceutical companies, and research institutes. Key growth factors include increasing legalization, consumer awareness, and ongoing research substantiating the efficacy of cannabis-based treatments. Additionally, potential opportunities lie in expanding regulatory approvals, developing novel delivery systems, and leveraging synergies with the biotechnology industry. However, the market faces limitations such as regulatory hurdles, varying regional acceptance, and high research costs. Intellectual property challenges and supply chain issues further compound these barriers. Furthermore, societal stigma and stringent clinical trial demands create significant challenges that hinder market expansion. To capitalize on growth, businesses should focus on innovations such as advanced extraction techniques, precise formulation methods, and personalized medicine approaches that cater to specific genetic profiles and conditions. The integration of AI and data analytics in research can offer insights into patient response variability and optimize product development pipelines. Overall, the market exhibits a dynamic nature, characterized by rapid advancements in technology and fluctuating legislative landscapes, presenting both opportunities and challenges for stakeholders. Establishing strong collaborations with research institutions and advocating for clearer regulatory frameworks can enhance growth prospects and facilitate smoother navigation through the evolving cannabis pharmaceuticals landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.71 billion
Forecast Year [2030] USD 4.82 billion
CAGR (%) 18.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cannabis Pharmaceuticals Market

The Cannabis Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the legalization of medicinal cannabis worldwide
    • Growing awareness about the medical benefits of cannabidiol and its remedial properties
    • Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
  • Market Restraints
    • High prices associated with medical cannabis
  • Market Opportunities
    • Rise in investments in cannabis-based pharmaceuticals
    • Growing availability through online and retail pharmacies
  • Market Challenges
    • Strict regulations in legalization of cannabis extract in several countries

Porter's Five Forces: A Strategic Tool for Navigating the Cannabis Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cannabis Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cannabis Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cannabis Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cannabis Pharmaceuticals Market

A detailed market share analysis in the Cannabis Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cannabis Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cannabis Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cannabis Pharmaceuticals Market

A strategic analysis of the Cannabis Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cannabis Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aphria, Inc., Aurora Cannabis, Inc., Bausch Health Companies, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Cannamedical Pharma GmbH, Canopy Growth Corporation, Cara Therapeutics Inc., CB Therapeutics Inc., Celadon Pharmaceuticals PLC, Corbus Pharmaceuticals Holdings, Inc., Cronos Group Inc. By Altria Group, Green Thumb Industries, Jazz Pharmaceuticals PLC, Medical Marijuana Inc., MGC Pharmaceuticals Limited, Panaxia Pharmaceutical Industries, Pascal Biosciences Inc., PharmaCyte Biotech, Inc., Renew Biopharma, Inc., Teva Pharmaceutical Industries Ltd., Tilray Brands, Inc., and Zynerba Pharmaceuticals, Inc. by Harmony Biosciences.

Market Segmentation & Coverage

This research report categorizes the Cannabis Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Brand, market is studied across Epidiolex and Sativex.
  • Based on Product Type, market is studied across Ointments & Creams and Solids and Dissolvable Powder & Oil.
  • Based on Indication, market is studied across Arthritis, Cancer, Epilepsy, and Migraine.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the legalization of medicinal cannabis worldwide
      • 5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
      • 5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High prices associated with medical cannabis
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in investments in cannabis-based pharmaceuticals
      • 5.1.3.2. Growing availability through online and retail pharmacies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations in legalization of cannabis extract in several countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cannabis Pharmaceuticals Market, by Brand

  • 6.1. Introduction
  • 6.2. Epidiolex
  • 6.3. Sativex

7. Cannabis Pharmaceuticals Market, by Product Type

  • 7.1. Introduction
  • 7.2. Ointments & Creams
  • 7.3. Solids and Dissolvable Powder & Oil

8. Cannabis Pharmaceuticals Market, by Indication

  • 8.1. Introduction
  • 8.2. Arthritis
  • 8.3. Cancer
  • 8.4. Epilepsy
  • 8.5. Migraine

9. Cannabis Pharmaceuticals Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Cannabis Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cannabis Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aphria, Inc.
  • 3. Aurora Cannabis, Inc.
  • 4. Bausch Health Companies, Inc.
  • 5. Botanix Pharmaceuticals
  • 6. Breath of Life Pharma, Ltd.
  • 7. Cannabis Science, Inc.
  • 8. Cannamedical Pharma GmbH
  • 9. Canopy Growth Corporation
  • 10. Cara Therapeutics Inc.
  • 11. CB Therapeutics Inc.
  • 12. Celadon Pharmaceuticals PLC
  • 13. Corbus Pharmaceuticals Holdings, Inc.
  • 14. Cronos Group Inc. By Altria Group
  • 15. Green Thumb Industries
  • 16. Jazz Pharmaceuticals PLC
  • 17. Medical Marijuana Inc.
  • 18. MGC Pharmaceuticals Limited
  • 19. Panaxia Pharmaceutical Industries
  • 20. Pascal Biosciences Inc.
  • 21. PharmaCyte Biotech, Inc.
  • 22. Renew Biopharma, Inc.
  • 23. Teva Pharmaceutical Industries Ltd.
  • 24. Tilray Brands, Inc.
  • 25. Zynerba Pharmaceuticals, Inc. by Harmony Biosciences

LIST OF FIGURES

  • FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. CANNABIS PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANNABIS PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023